FDA Inspection 1162361 - Biocon Generics Inc. - February 02, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Biocon Generics Inc.

Record Details

This FDA Inspection record concerns Biocon Generics Inc., with an inspection on February 2, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Biocon Generics Inc.
Inspection Date: February 2, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 49a9311f-111e-4b41-8361-590b86e8c1a2